Infusystem Hld Stock Price, News & Analysis

InfuSystem Holdings, Inc. (NYSE American: INFU) will release its third quarter 2020 financial results on November 12, 2020, before market opening. The company will host a conference call for investors at 9:00 a.m. Eastern Time on the same day to discuss the results. Interested participants can join via phone or a live webcast available on the company’s website. InfuSystem specializes in outpatient care, particularly through its Integrated Therapy Services and Durable Medical Equipment Services platforms.

InfuSystem Holdings to Present at Sidoti’s Fall 2020 Investor Conference

Rochester Hills, Michigan, Sept. 14, 2020 – InfuSystem (NYSE American: INFU) announced that CEO Richard DiIorio and CFO Barry Steele will present at Sidoti's Fall 2020 Investor Conference on September 23 at 3:15 p.m. ET via a virtual platform. The presentation will be available on InfuSystem's website. Additionally, the management will hold one-on-one meetings with investors on September 23-24. InfuSystem is a prominent national health care service provider, specializing in outpatient care for durable medical equipment.

InfuSystem Holdings, a national health care service provider focused on outpatient care, announced CEO Richard DiIorio and CFO Barry Steele will present at Lake Street's 4th Annual Best Ideas Growth (BIG4) Conference on September 17, 2020. The event will be held virtually, featuring one-on-one and group meetings with investors throughout the day. InfuSystem operates through Integrated Therapy Services and Durable Medical Equipment Services, ensuring comprehensive support for durable medical equipment.

InfuSystem Holdings, Inc. (NYSE American: INFU) announces its participation in the LD 500 Virtual Conference on September 1, 2020, at 9:40 a.m. ET. Richard DiIorio, CEO, and Barry Steele, CFO, will present at the event, which runs from September 1 to 4. InfuSystem is a national health care service provider specializing in outpatient care and durable medical equipment. Their services are divided into Integrated Therapy Services and Durable Medical Equipment Services, supporting various health care needs. More details can be found on their website.

InfuSystem Holdings reported record revenues of $26 million for Q2 2020, marking a 32% year-over-year increase. The net income surged to $4.1 million, up from $0.4 million last year, reflecting a tenfold growth. Adjusted EBITDA also rose significantly, reaching $8.5 million, an 87% increase. The company reestablished its full-year guidance, projecting revenues between $94 million and $97 million and adjusted EBITDA between $23 million and $26 million. However, management cautioned that the elevated demand driven by COVID-19 may not persist.

InfuSystem Holdings, Inc. (NYSE American: INFU) will release its second-quarter 2020 financial results on August 13, 2020, prior to market opening. A conference call for investors is scheduled for the same day at 9:00 a.m. Eastern Time to discuss the financial results. The call can be accessed by dialing (833) 366-1127 or via live webcast on the Company's website. InfuSystem is a national provider of infusion pumps and durable medical equipment services, serving hospitals and clinics across the U.S. and Canada.

InfuSystem Holdings, Inc. (NYSE American: INFU) announced its inclusion in the FTSE Russell 2000® Index, effective after market close on June 26, 2020. This milestone is expected to enhance the company's visibility among institutional investors, as stated by CEO Richard DiIorio. InfuSystem, a provider of infusion pumps and related support services, aims to build on its operational success and expand into new therapies. The Russell 2000® Index is a key benchmark for small-cap companies, covering a significant portion of the market.

InfuSystem, a health care service provider, will present at the Lytham Partners Virtual Investor Conference on May 20, 2020, at 1:00 p.m. ET. CEO Richard DiIorio and CFO Barry Steele will speak at the event. A webcast of the presentation can be accessed on the company’s website, with a replay available afterward. Management will also hold virtual one-on-one meetings on May 21, 2020. InfuSystem offers infusion pumps and durable medical equipment support services and operates multiple Centers of Excellence across North America. Its stock is traded under the symbol INFU.

InfuSystem Holdings reported first quarter 2020 net revenues of $21.6 million, an increase of 18% year-over-year, driven by growth in both segments. Gross profit rose 22% to $12.7 million, with a gross margin of 58.8%. The company achieved an adjusted EBITDA of $4.1 million, marking a 30% increase. The net loss improved to $(0.4 million) or $(0.02) per diluted share. Despite challenges from COVID-19, oncology billings reached record levels. However, pain management revenues declined due to elective surgery delays, impacting overall performance.